Literature DB >> 17878464

Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should).

Alvar Agustí1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is associated with pulmonary and systemic inflammation. The latter is likely to contribute significantly to the pathobiology of numerous extrapulmonary effects of the disease--the so-called systemic effects of COPD. The clinical relevance of these systemic effects has been recently recognized; however, many important questions about its pathophysiology remain unanswered. This article reviews what is known about it and, more importantly, highlights what is not (but should be) known in order to stimulate research in this area, in the hope that a better understanding of this field may lead to better treatment options for patients with COPD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878464     DOI: 10.1513/pats.200701-004FM

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  68 in total

1.  Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function.

Authors:  Weiliang Qiu; Andrea Baccarelli; Vincent J Carey; Nadia Boutaoui; Helene Bacherman; Barbara Klanderman; Stephen Rennard; Alvar Agusti; Wayne Anderson; David A Lomas; Dawn L DeMeo
Journal:  Am J Respir Crit Care Med       Date:  2011-12-08       Impact factor: 21.405

Review 2.  Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Authors:  Marios Panagiotou; Andrew J Peacock; Martin K Johnson
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

3.  C-reactive protein levels are raised in stable Chronic obstructive pulmonary disease patients independent of smoking behavior and biomass exposure.

Authors:  Funda Aksu; Nermin Capan; Kurtuluş Aksu; Ruhsar Ofluoğlu; Sema Canbakan; Bünyamin Yavuz; Kadir Okhan Akin
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 4.  Sleep-disordered breathing and COPD: the overlap syndrome.

Authors:  Robert L Owens; Atul Malhotra
Journal:  Respir Care       Date:  2010-10       Impact factor: 2.258

Review 5.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 6.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

7.  Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice.

Authors:  Yoshito Takeda; Ping He; Isao Tachibana; Bo Zhou; Kenji Miyado; Hideshi Kaneko; Mayumi Suzuki; Seigo Minami; Takeo Iwasaki; Sho Goya; Takashi Kijima; Toru Kumagai; Mitsuhiro Yoshida; Tadashi Osaki; Toshihisa Komori; Eisuke Mekada; Ichiro Kawase
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

8.  Natural histories of chronic obstructive pulmonary disease.

Authors:  Stephen I Rennard; Jørgen Vestbo
Journal:  Proc Am Thorac Soc       Date:  2008-12-15

9.  Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Authors:  Francisco Garcia-Rio; Marc Miravitlles; Joan B Soriano; Luis Muñoz; Enric Duran-Tauleria; Guadalupe Sánchez; Víctor Sobradillo; Julio Ancochea
Journal:  Respir Res       Date:  2010-05-25

Review 10.  Influencing the decline of lung function in COPD: use of pharmacotherapy.

Authors:  Ekaterina S Gladysheva; Atul Malhotra; Robert L Owens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.